Xcout Intel
Cadenza Bio, Inc.
Cadenza Bio, Inc. is a privately held preclinical biotechnology company founded in 2022 and headquartered in Oklahoma City, dedicated to developing novel, non-steroidal, highly selective small-molecule therapies.
Subscribe to see Cadenza Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cadenza Bio, Inc. at a glance
Cadenza Bio, Inc. is a biotechnology company headquartered in United States. Its most recent funding round, Seed, raised $2.4M in December 2023. Xcout tracks 6 named people at Cadenza Bio, Inc., including Carol Curtis (CEO).
Cadenza Bio, Inc. leadership
- Carol CurtisCEO
- David MartinCHIEF DEVELOPMENT OFFICER
- Carol CurtisCHIEF EXECUTIVE OFFICER, FOUNDER
- Elaine HammCHIEF OPERATING OFFICER, FOUNDER
- John KatzenellenbogenSCIENTIFIC FOUNDER
- Seema Tiwari-WoodruffSCIENTIFIC FOUNDER
Cadenza Bio, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $2.4M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Cadenza Bio, Inc. competitors
A few of Cadenza Bio, Inc.'s closest competitors — see the full list of competitors and alternatives →
Cadre Bioscience is a biopharmaceutical company headquartered in St. Louis, Missouri. The company employs a lean business model to accelerate the development of multiple diverse early-stage therapeutic assets.
Brenig Therapeutics, Inc. is a clinical-stage biotechnology and drug development company focused on advancing small-molecule therapies.
Ollin Biosciences is a clinical-stage biopharmaceutical holding company established in 2023 and headquartered in Austin, Texas, dedicated to developing therapeutics.
Oxalo Therapeutics, Inc. is a privately held biotechnology and therapeutics company founded in 2018 and based in Chicago, Illinois, dedicated to developing first-in-class treatments to treat and prevent disease targets.
EpimedX LLC is an early-stage biotechnology company based in Oklahoma City, Oklahoma, that is developing novel gene regulation and drug therapies to treat blood diseases such as sickle cell disease, beta-thalassemia, and malaria.
Bolden Therapeutics, Inc. is a privately held biotechnology company founded in 2019 and headquartered in Providence, Rhode Island, with corporate office space in Boston, Massachusetts. The company is dedicated to developing first-in-class therapeutics.
Get Cadenza Bio, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cadenza Bio, Inc. in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access